Publication
Title
Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC
Author
Language
English
Source (journal)
Anti-cancer drugs: an international journal on anti-cancer agents. - Philadelphia, Pa
Publication
Philadelphia, Pa : 2005
ISSN
0959-4973
Volume/pages
16:8(2005), p. 871-877
ISI
000231867800011
Full text (Publisher's DOI)
UAntwerpen
Faculty/Department
Research group
Publication type
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 08.10.2008
Last edited 07.09.2017
To cite this reference